Overview

Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla

Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
In this clinical cohort study, the investigators observe the efficacy of low molecular weight heparin in the treatment of thrombophilia with recurrent pregnancy loss with a prospective randomized controlled trial.
Phase:
Phase 4
Details
Lead Sponsor:
Shanghai First Maternity and Infant Hospital
Treatments:
Aspirin
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight